Trial Profile
A phase I study for RG7604 in solid tumours in Japan
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 12 Dec 2014
Price :
$35
*
At a glance
- Drugs Taselisib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 11 Dec 2014 New trial record